ACE - Full Year Results to 31 March 2022 / Annual Report

- the Company completed a 100 to 1 share consolidation in November 2021. As result of the consolidation, and after taking account of rounding of entitlements, the number of shares on issue in Ascension reduced from 1,914,888,105 to 19,148,828.

- there were no changes in the board of directors.

The focus of the Board going forward is to identify a suitable business opportunity to invest in and/or acquire through a reverse takeover transaction. Currently, there are no initiatives being investigated, but the Company will provide the market with any updates as to material developments in due course.

The financial result for the Company for the year ended 31 March 2022 is a loss after taxation of NZ$171,171, which is largely made up of the directors’ fees, NZX listing costs, and legal and accounting costs.

•  ACE Results for release to the market
•  ACE Annual Report 2022

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

OCA - Oceania Healthcare launches secured fixed rate bond offer
ATM - a2MC receives SAMR approval
June 22nd Morning Report
SPG - Retirement of Director Michelle Tierney
APL - AGM Date and Director Nominations
SKC - Resolution of Adelaide Independent Review
CMC Markets accredited as NZX Participant
June 18th Morning Report
PCT - Sale of PwC Tower to New Investment Partnership
MEL - Waitaki reconsenting receives final approval